Abstract
The mortality of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) remain high despite advances in our knowledge and intensive care. This supports the contention that we need to further our understanding of the mediators that are involved in the pathogenesis of ARDS. The pathogenesis of ARDS proceeds as a continuum from exudation and inflammation to a fibroproliferative phase of diffuse alveolar damage. While a number of mediators are involved in the pathogenesis of ARDS, members of the CXC chemokine family have been determined to play a critical and pleiotropic role in promoting both recruitment of inflammatory cells, as well as in mediating aberrant vascular remodeling during both phases of ARDS. The importance of the biology of CXC chemokines in ALI/ARDS will be discussed in this review.
Keywords: chemokines, cytokines, and acute lung injury
Current Drug Targets - Inflammation & Allergy
Title: The Role of CXCR2/CXCR2 Ligands in Acute Lung Injury
Volume: 4 Issue: 3
Author(s): Robert M. Strieter, Michael P. Keane, Marie D. Burdick, Ammar Sakkour, Lynne A. Murray and John A. Belperio
Affiliation:
Keywords: chemokines, cytokines, and acute lung injury
Abstract: The mortality of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) remain high despite advances in our knowledge and intensive care. This supports the contention that we need to further our understanding of the mediators that are involved in the pathogenesis of ARDS. The pathogenesis of ARDS proceeds as a continuum from exudation and inflammation to a fibroproliferative phase of diffuse alveolar damage. While a number of mediators are involved in the pathogenesis of ARDS, members of the CXC chemokine family have been determined to play a critical and pleiotropic role in promoting both recruitment of inflammatory cells, as well as in mediating aberrant vascular remodeling during both phases of ARDS. The importance of the biology of CXC chemokines in ALI/ARDS will be discussed in this review.
Export Options
About this article
Cite this article as:
Strieter M. Robert, Keane P. Michael, Burdick D. Marie, Sakkour Ammar, Murray A. Lynne and Belperio A. John, The Role of CXCR2/CXCR2 Ligands in Acute Lung Injury, Current Drug Targets - Inflammation & Allergy 2005; 4 (3) . https://dx.doi.org/10.2174/1568010054022178
DOI https://dx.doi.org/10.2174/1568010054022178 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Statins May Prevent Atherosclerotic Disease in OSA Patients without Co-Morbidities?
Current Vascular Pharmacology Complex of Nifedipine with Glycyrrhizic Acid as a Novel Water-Soluble Antihypertensive and Antiarrhythmic Agent
Letters in Drug Design & Discovery The Role of Microbiota and Probiotics in Stress-Induced Gastrointestinal Damage
Current Molecular Medicine Natural Immunity Boosters as Therapeutic Interventions in the Era of the COVID-19 Pandemic
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
Current Drug Targets Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction
Current Protein & Peptide Science Role of Transforming Growth Factor Beta in Corneal Function, Biology and Pathology
Current Molecular Medicine When Does Food Refusal Require Professional Intervention?
Current Nutrition & Food Science Recent Patents in Oncolytic Virotherapy
Recent Patents on Biotechnology Chemical Instability Determines the Biological Action of the Artemisinins
Current Medicinal Chemistry Therapeutics Based on microRNA: A New Approach for Liver Cancer
Current Genomics COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment
Current Pharmaceutical Design Review in Quantitative Structure Activity Relationships on Lipoxygenase Inhibitors
Mini-Reviews in Medicinal Chemistry Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery ACKNOWLEDGEMENTS TO CONTRIBUTORS
Recent Patents on Inflammation & Allergy Drug Discovery The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer
Current Cancer Drug Targets Future Therapeutic Strategies in Inflammatory Cardiomyopathy: Insights from the Experimental Autoimmune Myocarditis Model
Cardiovascular & Hematological Disorders-Drug Targets Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes
Current Medicinal Chemistry The Potential Roles of <i>Ficus carica</i> Extract in the Management of COVID-19 Viral Infections: A Computer-aided Drug Design Study
Current Computer-Aided Drug Design